Related Experiment Video
Updated: Jun 13, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
OPA1 mutations associated with dominant optic atrophy influence optic nerve head size
Piero Barboni1, Michele Carbonelli, Giacomo Savini
1Studio Oculistico d'Azeglio, Bologna, Italy. p.barboni@studiodazeglio.it
Opa1 gene mutations in dominant optic atrophy (DOA) patients are linked to a smaller optic nerve head (ONH) size. This finding suggests OPA1
Area of Science:
- Ophthalmology and Genetics
- Optic Nerve Head Morphology
- Dominant Optic Atrophy (DOA)
Background:
- Dominant optic atrophy (DOA) is a hereditary condition affecting the optic nerve.
- The OPA1 gene plays a crucial role in mitochondrial dynamics and optic nerve health.
- Understanding the impact of OPA1 mutations on optic nerve head (ONH) structure is vital for elucidating DOA pathogenesis.
Purpose of the Study:
- To investigate the influence of OPA1 gene mutations on the morphology of the optic nerve head (ONH) in patients diagnosed with dominant optic atrophy (DOA).
- To compare ONH parameters between DOA patients with OPA1 mutations and age-matched healthy controls.
Main Methods:
- A cross-sectional study design was employed.
- Twenty-eight patients with DOA and confirmed OPA1 mutations from 11 pedigrees were included.
- Optical coherence tomography (OCT) was used to analyze ONH morphology (area, vertical and horizontal diameters) in patients and 56 age-matched controls.
Main Results:
- DOA patients with OPA1 mutations exhibited significantly smaller optic disc area, vertical diameter, and horizontal diameter compared to controls.
- Specific OPA1 mutations showed varying effects on ONH size; two mutations were associated with normal ONH area.
- The missense mutation linked to the 'DOA plus' phenotype resulted in the smallest ONH measurements.
Conclusions:
- Patients with OPA1 gene mutations present with a significantly smaller optic nerve head (ONH) compared to the general population.
- The observed smaller ONH size in DOA patients may be mutation-specific, suggesting OPA1's role in ONH development and structure.
- These findings highlight a potential link between OPA1 gene mutations, reduced ONH size, and the pathogenesis of dominant optic atrophy.
More Related Videos
10:10Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
Published on: November 2, 2018
08:55Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Genetic Lingo
Photoreceptors and Visual Pathways